rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
23
|
pubmed:dateCreated |
1993-12-21
|
pubmed:abstractText |
The biotransformation of the natural estrogen 17 beta-estradiol (E2) via the C16 alpha-hydroxylation pathway is elevated in patients with breast cancer, in subjects at increased risk for developing breast cancer, and in c-Ha-ras-initiated mouse mammary epithelial cells.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0027-8874
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1917-20
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8230281-Adolescent,
pubmed-meshheading:8230281-Adult,
pubmed-meshheading:8230281-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:8230281-Breast Neoplasms,
pubmed-meshheading:8230281-Culture Techniques,
pubmed-meshheading:8230281-Cytochrome P-450 Enzyme System,
pubmed-meshheading:8230281-Estradiol,
pubmed-meshheading:8230281-Female,
pubmed-meshheading:8230281-Humans,
pubmed-meshheading:8230281-Hydroxylation,
pubmed-meshheading:8230281-Mammaplasty,
pubmed-meshheading:8230281-Mastectomy,
pubmed-meshheading:8230281-Middle Aged,
pubmed-meshheading:8230281-Reference Values,
pubmed-meshheading:8230281-Steroid 16-alpha-Hydroxylase,
pubmed-meshheading:8230281-Steroid Hydroxylases,
pubmed-meshheading:8230281-Tumor Markers, Biological,
pubmed-meshheading:8230281-Up-Regulation
|
pubmed:year |
1993
|
pubmed:articleTitle |
Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
|
pubmed:affiliation |
Strang-Cornell Cancer Research Laboratory, Strand Cancer Prevention Center, New York, N.Y. 10021.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|